Beijing Science Sun Pharmaceutical Co Ltd (300485) — Strategic Asset Allocation Index
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Strategic Asset Allocation Index of 15.4% as of June 2023. Strategic assets (PP&E of CN¥556.37 Million plus long-term investments of CN¥-) total CN¥556.37 Million, measured against net assets of CN¥3.62 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Beijing Science Sun Pharmaceutical Co Lt to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Beijing Science Sun Pharmaceutical Co Ltd Strategic Asset Allocation Index (2012–2022)
This chart shows how Beijing Science Sun Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 15.4%, representing strategic assets of CN¥556.37 Million against net assets of CN¥3.62 Billion CNY. For live market cap and overall valuation, see 300485 market cap.
Annual Strategic Asset Allocation Index for Beijing Science Sun Pharmaceutical Co Ltd (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Beijing Science Sun Pharmaceutical Co Ltd from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Beijing Science Sun Pharmaceutical Co Lt (300485) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 16.8% | CN¥572.18 Million | CN¥572.18 Million | CN¥- | CN¥3.41 Billion | ▼ -1.5 pp |
| 2021 | 18.2% | CN¥598.90 Million | CN¥598.90 Million | CN¥- | CN¥3.28 Billion | ▼ -3.5 pp |
| 2020 | 21.7% | CN¥619.70 Million | CN¥619.70 Million | CN¥- | CN¥2.85 Billion | ▲ +0.9 pp |
| 2019 | 20.8% | CN¥564.01 Million | CN¥564.01 Million | CN¥- | CN¥2.71 Billion | ▼ -7.4 pp |
| 2018 | 28.2% | CN¥721.14 Million | CN¥459.11 Million | CN¥262.03 Million | CN¥2.56 Billion | ▲ +4.3 pp |
| 2017 | 23.9% | CN¥554.34 Million | CN¥323.68 Million | CN¥230.66 Million | CN¥2.32 Billion | ▲ +3.5 pp |
| 2016 | 20.4% | CN¥428.18 Million | CN¥218.08 Million | CN¥210.09 Million | CN¥2.10 Billion | ▲ +9.0 pp |
| 2015 | 11.4% | CN¥213.90 Million | CN¥108.90 Million | CN¥105.00 Million | CN¥1.88 Billion | ▼ -5.4 pp |
| 2014 | 16.7% | CN¥108.31 Million | CN¥108.31 Million | CN¥- | CN¥646.64 Million | ▼ -6.7 pp |
| 2013 | 23.5% | CN¥115.91 Million | CN¥115.91 Million | CN¥- | CN¥493.71 Million | ▼ -5.5 pp |
| 2012 | 29.0% | CN¥104.44 Million | CN¥104.44 Million | CN¥- | CN¥359.96 Million | — |